$NRED is taking a very different path now New CEO Valentin Saitarli brings an AI and computer vision background, while the company shifts toward MetalCore,mining robotics and automation This is starting to look more like a mining-tech story than a traditional junior miner $CAT

The bigger picture behind the latest $RYET news is much larger than one Malaysia agreement AI in healthcare is becoming a global industry. Current market estimates put the sector at roughly $56B in 2026, with forecasts reaching around $1 TRILLION by 2034. That is the market backdrop for RYET latest move. Ruanyun announced a definitive agreement involving Cogni AI and BioNexus Gene Lab in Malaysia, giving its AI technology a path into healthcare rather than keeping it limited to education and enterprise applications. The structure is interesting too: an exclusive license framework of up to 20 years, 10% royalty economics on qualifying technology receipts, and 560K BGLC shares at closing. For me, this is what makes the news important. RYET is not suddenly becoming a healthcare giant. It is testing whether Cogni AI can be licensed into a completely different industry and international market while that industry itself is experiencing massive AI adoption. Education was the starting point. Enterprise AI expanded the story. Now healthcare adds another potential use case. If Cogni AI can continue moving across industries and markets, that becomes a much more interesting business model than relying on one product or one sector. Malaysia may be only the first healthcare test, but it puts RYET directly in front of one of the fastest-growing global technology trends.

$RYET is expanding its AI story into a new market. The company announced a Malaysia healthcare agreement involving Cogni AI and BioNexus Gene Lab, adding another real-world use case to its international strategy. Interesting development to follow $AVGO $MU $INTC $SMCI $ARM $QCOM $ORCL

$RYET the Malaysia healthcare deal with BioNexus gives Cogni AI a new commercial path, with up to 20 years of exclusivity, 10% royalty economics and 560K BGLC shares at closing New market. New vertical. More attention on the story.

BREAKING: $RYET is entering Malaysian healthcare New Cogni AI deal with BioNexus includes an exclusive license for up to 20 years, 10% royalty economics and 560K BGLC shares at closing. New vertical. New market. Bigger global story

AI + education is becoming a bigger global theme. $RYET is expanding beyond China with smart campus tools, AI platforms and international education projects, while preliminary H1 FY2027 revenue is expected at $9.3M-$9.5M

Watching $NVDA $RYET $AMD $MSFT and other active names? Daily Market Memo sends market research, company news and fresh catalysts straight to your inbox so you can spot what deserves a closer look No hype. Just useful market context Join free: dailymarketmemo.com/email

I’m watching $RYET very closely into Monday The new revenue numbers completely changed how I look at this setup. When a small-cap suddenly shows $9.3M-$9.5M expected H1 revenue, people start paying attention fast If volume comes in, this could get interesting

One number changes the $RYET story today: $9.3M-$9.5M That’s expected H1 FY2027 revenue - versus only ~$0.37M in H1 FY2026 And it already tops the company’s $7.48M FY2026 full-year revenue This is the revenue update traders should be watching

$RYET NEWS: preliminary H1 FY2027 revenue is expected at $9.3M-$9.5M, already above FY2026 full-year revenue of $7.48M Smart Campus alone is expected at $5.0M-$5.2M A major scale-up to watch globenewswire.com/de/news-re…